Follicum’s patent strategy is to secure a broad patent protection for the company’s product candidates. The company has received patent protection in major markets for the product candidate FOL-005, and variants thereof, both for the treatment of hair growth and inhibition of hair growth. Follicum is constantly reviewing all opportunities to improve the patent situation and the company will actively pursue an offensive patenting strategy to secure its future position. The company’s global patent strategy is focused on creating exclusivity and optimizing the value of the company’s product portfolio, especially in markets of high value for outlicensing.
|Patent Family||Patent Application||Approved Patents||Validity|
|Patent 1: Stimulation of hair growth||Australia, Brazil, Canada, China, Europe, Hong Kong, India, Japan, Russia, South Korea, USA||Australia, China, Europe (Austria, Belgium, Denmark, Finland, France, Germany, Great Britain, Ireland, Italy, Netherlands, Norway, Poland, Switzerland, Spain, Sweden, Turkey), Hong Kong, Japan, Russia, USA||2032|
|Patent 2: Inhibition of hair growth||Australia, Brazil, Canada, China, Europe, Israel, Japan, Mexico, Russia, Singapore, South Africa, South Korea, USA||Pending||2035|